Merck to Acquire Bio-Techne for $11.3 Billion, Driving Stock Up 20% Year-to-Date
German company Merck KGaA (MKKGY) announced a definitive agreement to acquire Bio-Techne (TECH) in an all-cash deal valued at approximately $11.3 billion, representing a 24% premium over TECH's previous closing price. The acquisition is expected to strengthen Merck’s position in the life sciences market and has driven TECH shares up by around 20% since the start of the year.
Tickers: $TECH